A study of Hematopoietic Stem Cell Transplantation (HSCT) in Non-Malignant Disease using a Reduced-Intensity preparatory regime with Campath-1H Fludarabine and Melphalan

Study Overview

The overall purpose of this research is to treat diseases that are not cancer but are improved by bone marrow transplantation.

Study Description

The overall purpose of this research is to treat diseases that are not cancer but are improved by bone marrow transplantation.

Additional Information

Participants will not be paid for their participation.


  • IRB Number: 1010002807
  • Research Study Identifier: TX782
  • Principal Investigator: Paul Haut, MD

Recruitment Status

Open

Contact the research team to learn more about this study.

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Registry

Create your profile and be matched to research opportunities

Register Now!

If you need assistance finding a study or if you have any questions, please email: ctsirro@iu.edu or call us at (317) 278-2176